Key facts
- This page summarizes Anne Clem Whitaker's Form 4 filing for CALADRIUS BIOSCIENCES, INC. (LSTA).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 12 Jan 2022, 15:17.
Anne Clem Whitaker - 10 Jan 2022 Form 4 Insider Report for CALADRIUS BIOSCIENCES, INC. (LSTA)
- Reporting relationship
- Director
- Issuer ticker
- LSTA
- Reported as of
- 10 Jan 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 12 Jan 2022, 15:17:01 UTC
- Prior SEC filing
- 10 Nov 2021
- Next SEC filing
- 18 May 2022
- Source filing
- View source filing
- Reporting owner signature
- Anne Clem Whitaker, by /s/ Todd Girolamo, Esq., Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Anne Clem Whitaker filed Form 4 for CALADRIUS BIOSCIENCES, INC. (LSTA) on 12 Jan 2022.
Change
- Previous filing in this sequence was filed on 10 Nov 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LSTA
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +65,430
- Change %
- +56%
- Price
- $0.000000
- Shares after
- 182,635
- Date
- 10 Jan 2022
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents 65,430 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 10, 2023.
Footnote F2
Includes 156,145 unvested restricted stock units.